Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-050050

Principal Accounting Officer sold 312 shares at $83.00 ($25,896)

  • Principal Accounting Officer acquired 312 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Alenson Carman Principal Accounting Officer 2018-09-05 Option exercise +312 $52.29 $16,314 464 D
Alenson Carman Principal Accounting Officer 2018-09-05 Sale −312 $83.00 $25,896 152 D
Derivatives
Alenson Carman Principal Accounting Officer 2018-09-05 Option exercise · Stock option (right to buy) −312 12,266 D
Open-market sales · 312 sh · avg $83.00 · $25,896
Loading xslF345X03/doc4.xml…